 | • レポートコード：MRC2Q12-19051 • 出版社/出版日：QYResearch / 2022年12月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥710,500 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,421,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、フィブリン系生体接着剤のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 フィブリン系生体接着剤のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 フィブリン系生体接着剤の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 フィブリン系生体接着剤のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのフィブリン系生体接着剤の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のフィブリン系生体接着剤の売上および2028年までの予測に焦点を当てています。 フィブリン系生体接着剤のグローバル主要企業には、Baxter International、Integra LifeSciences、McKesson Corporation、Vivostat A/S、Ethicon (Johnson & Johnson)、Becton Dickinson、Adhezion Biomedicalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 フィブリン系生体接着剤市場は、タイプとアプリケーションによって区分されます。世界のフィブリン系生体接着剤市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 創傷閉鎖、シーリング漏れ、固定化 【アプリケーション別セグメント】 病院、外来手術センター、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - フィブリン系生体接着剤製品概要 - タイプ別市場（創傷閉鎖、シーリング漏れ、固定化） - アプリケーション別市場（病院、外来手術センター、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のフィブリン系生体接着剤販売量予測2017-2028 - 世界のフィブリン系生体接着剤売上予測2017-2028 - フィブリン系生体接着剤の地域別販売量 - フィブリン系生体接着剤の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別フィブリン系生体接着剤販売量 - 主要メーカー別フィブリン系生体接着剤売上 - 主要メーカー別フィブリン系生体接着剤価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（創傷閉鎖、シーリング漏れ、固定化） - フィブリン系生体接着剤のタイプ別販売量 - フィブリン系生体接着剤のタイプ別売上 - フィブリン系生体接着剤のタイプ別価格 ・アプリケーション別市場規模（病院、外来手術センター、その他） - フィブリン系生体接着剤のアプリケーション別販売量 - フィブリン系生体接着剤のアプリケーション別売上 - フィブリン系生体接着剤のアプリケーション別価格 ・北米市場 - 北米のフィブリン系生体接着剤市場規模（タイプ別、アプリケーション別） - 主要国別のフィブリン系生体接着剤市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのフィブリン系生体接着剤市場規模（タイプ別、アプリケーション別） - 主要国別のフィブリン系生体接着剤市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のフィブリン系生体接着剤市場規模（タイプ別、アプリケーション別） - 主要国別のフィブリン系生体接着剤市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のフィブリン系生体接着剤市場規模（タイプ別、アプリケーション別） - 主要国別のフィブリン系生体接着剤市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのフィブリン系生体接着剤市場規模（タイプ別、アプリケーション別） - 主要国別のフィブリン系生体接着剤市場規模（トルコ、サウジアラビア） ・企業情報 Baxter International、Integra LifeSciences、McKesson Corporation、Vivostat A/S、Ethicon (Johnson & Johnson)、Becton Dickinson、Adhezion Biomedical ・産業チェーン及び販売チャネル分析 - フィブリン系生体接着剤の産業チェーン分析 - フィブリン系生体接着剤の原材料 - フィブリン系生体接着剤の生産プロセス - フィブリン系生体接着剤の販売及びマーケティング - フィブリン系生体接着剤の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - フィブリン系生体接着剤の産業動向 - フィブリン系生体接着剤のマーケットドライバー - フィブリン系生体接着剤の課題 - フィブリン系生体接着剤の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Fibrin Based Bioadhesive is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Fibrin Based Bioadhesive is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Fibrin Based Bioadhesive is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Fibrin Based Bioadhesive include Baxter International, Integra LifeSciences, McKesson Corporation, Vivostat A/S, Ethicon (Johnson & Johnson), Becton Dickinson and Adhezion Biomedical, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Fibrin Based Bioadhesive manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Fibrin Based Bioadhesive market. Further, it explains the major drivers and regional dynamics of the global Fibrin Based Bioadhesive market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Baxter International
Integra LifeSciences
McKesson Corporation
Vivostat A/S
Ethicon (Johnson & Johnson)
Becton Dickinson
Adhezion Biomedical
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Fibrin Based Bioadhesive Segment by Type
Wound Closure
Sealing Leakage
Immobilization
Fibrin Based Bioadhesive Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Fibrin Based Bioadhesive market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Fibrin Based Bioadhesive, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Fibrin Based Bioadhesive, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Fibrin Based Bioadhesive, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Fibrin Based Bioadhesive sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Fibrin Based Bioadhesive market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Fibrin Based Bioadhesive sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Baxter International, Integra LifeSciences, McKesson Corporation, Vivostat A/S, Ethicon (Johnson & Johnson), Becton Dickinson and Adhezion Biomedical, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Fibrin Based Bioadhesive in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Fibrin Based Bioadhesive manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fibrin Based Bioadhesive sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Fibrin Based Bioadhesive Product Introduction
1.2 Market by Type
1.2.1 Global Fibrin Based Bioadhesive Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Wound Closure
1.2.3 Sealing Leakage
1.2.4 Immobilization
1.3 Market by Application
1.3.1 Global Fibrin Based Bioadhesive Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Fibrin Based Bioadhesive Sales Estimates and Forecasts 2017-2028
2.2 Global Fibrin Based Bioadhesive Revenue Estimates and Forecasts 2017-2028
2.3 Global Fibrin Based Bioadhesive Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Fibrin Based Bioadhesive Sales by Region
2.4.1 Global Fibrin Based Bioadhesive Sales by Region (2017-2022)
2.4.2 Global Sales Fibrin Based Bioadhesive by Region (2023-2028)
2.5 Global Fibrin Based Bioadhesive Revenue by Region
2.5.1 Global Fibrin Based Bioadhesive Revenue by Region (2017-2022)
2.5.2 Global Fibrin Based Bioadhesive Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Fibrin Based Bioadhesive Sales by Manufacturers
3.1.1 Global Top Fibrin Based Bioadhesive Manufacturers by Sales (2017-2022)
3.1.2 Global Fibrin Based Bioadhesive Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Fibrin Based Bioadhesive in 2021
3.2 Global Fibrin Based Bioadhesive Revenue by Manufacturers
3.2.1 Global Fibrin Based Bioadhesive Revenue by Manufacturers (2017-2022)
3.2.2 Global Fibrin Based Bioadhesive Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Fibrin Based Bioadhesive Revenue in 2021
3.3 Global Fibrin Based Bioadhesive Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Fibrin Based Bioadhesive Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Fibrin Based Bioadhesive Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Fibrin Based Bioadhesive Sales by Type
4.1.1 Global Fibrin Based Bioadhesive Historical Sales by Type (2017-2022)
4.1.2 Global Fibrin Based Bioadhesive Forecasted Sales by Type (2023-2028)
4.1.3 Global Fibrin Based Bioadhesive Sales Market Share by Type (2017-2028)
4.2 Global Fibrin Based Bioadhesive Revenue by Type
4.2.1 Global Fibrin Based Bioadhesive Historical Revenue by Type (2017-2022)
4.2.2 Global Fibrin Based Bioadhesive Forecasted Revenue by Type (2023-2028)
4.2.3 Global Fibrin Based Bioadhesive Revenue Market Share by Type (2017-2028)
4.3 Global Fibrin Based Bioadhesive Price by Type
4.3.1 Global Fibrin Based Bioadhesive Price by Type (2017-2022)
4.3.2 Global Fibrin Based Bioadhesive Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Fibrin Based Bioadhesive Sales by Application
5.1.1 Global Fibrin Based Bioadhesive Historical Sales by Application (2017-2022)
5.1.2 Global Fibrin Based Bioadhesive Forecasted Sales by Application (2023-2028)
5.1.3 Global Fibrin Based Bioadhesive Sales Market Share by Application (2017-2028)
5.2 Global Fibrin Based Bioadhesive Revenue by Application
5.2.1 Global Fibrin Based Bioadhesive Historical Revenue by Application (2017-2022)
5.2.2 Global Fibrin Based Bioadhesive Forecasted Revenue by Application (2023-2028)
5.2.3 Global Fibrin Based Bioadhesive Revenue Market Share by Application (2017-2028)
5.3 Global Fibrin Based Bioadhesive Price by Application
5.3.1 Global Fibrin Based Bioadhesive Price by Application (2017-2022)
5.3.2 Global Fibrin Based Bioadhesive Price Forecast by Application (2023-2028)
6 North America
6.1 North America Fibrin Based Bioadhesive Market Size by Type
6.1.1 North America Fibrin Based Bioadhesive Sales by Type (2017-2028)
6.1.2 North America Fibrin Based Bioadhesive Revenue by Type (2017-2028)
6.2 North America Fibrin Based Bioadhesive Market Size by Application
6.2.1 North America Fibrin Based Bioadhesive Sales by Application (2017-2028)
6.2.2 North America Fibrin Based Bioadhesive Revenue by Application (2017-2028)
6.3 North America Fibrin Based Bioadhesive Market Size by Country
6.3.1 North America Fibrin Based Bioadhesive Sales by Country (2017-2028)
6.3.2 North America Fibrin Based Bioadhesive Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Fibrin Based Bioadhesive Market Size by Type
7.1.1 Europe Fibrin Based Bioadhesive Sales by Type (2017-2028)
7.1.2 Europe Fibrin Based Bioadhesive Revenue by Type (2017-2028)
7.2 Europe Fibrin Based Bioadhesive Market Size by Application
7.2.1 Europe Fibrin Based Bioadhesive Sales by Application (2017-2028)
7.2.2 Europe Fibrin Based Bioadhesive Revenue by Application (2017-2028)
7.3 Europe Fibrin Based Bioadhesive Market Size by Country
7.3.1 Europe Fibrin Based Bioadhesive Sales by Country (2017-2028)
7.3.2 Europe Fibrin Based Bioadhesive Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Fibrin Based Bioadhesive Market Size by Type
8.1.1 Asia Pacific Fibrin Based Bioadhesive Sales by Type (2017-2028)
8.1.2 Asia Pacific Fibrin Based Bioadhesive Revenue by Type (2017-2028)
8.2 Asia Pacific Fibrin Based Bioadhesive Market Size by Application
8.2.1 Asia Pacific Fibrin Based Bioadhesive Sales by Application (2017-2028)
8.2.2 Asia Pacific Fibrin Based Bioadhesive Revenue by Application (2017-2028)
8.3 Asia Pacific Fibrin Based Bioadhesive Market Size by Region
8.3.1 Asia Pacific Fibrin Based Bioadhesive Sales by Region (2017-2028)
8.3.2 Asia Pacific Fibrin Based Bioadhesive Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Fibrin Based Bioadhesive Market Size by Type
9.1.1 Latin America Fibrin Based Bioadhesive Sales by Type (2017-2028)
9.1.2 Latin America Fibrin Based Bioadhesive Revenue by Type (2017-2028)
9.2 Latin America Fibrin Based Bioadhesive Market Size by Application
9.2.1 Latin America Fibrin Based Bioadhesive Sales by Application (2017-2028)
9.2.2 Latin America Fibrin Based Bioadhesive Revenue by Application (2017-2028)
9.3 Latin America Fibrin Based Bioadhesive Market Size by Country
9.3.1 Latin America Fibrin Based Bioadhesive Sales by Country (2017-2028)
9.3.2 Latin America Fibrin Based Bioadhesive Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Fibrin Based Bioadhesive Market Size by Type
10.1.1 Middle East and Africa Fibrin Based Bioadhesive Sales by Type (2017-2028)
10.1.2 Middle East and Africa Fibrin Based Bioadhesive Revenue by Type (2017-2028)
10.2 Middle East and Africa Fibrin Based Bioadhesive Market Size by Application
10.2.1 Middle East and Africa Fibrin Based Bioadhesive Sales by Application (2017-2028)
10.2.2 Middle East and Africa Fibrin Based Bioadhesive Revenue by Application (2017-2028)
10.3 Middle East and Africa Fibrin Based Bioadhesive Market Size by Country
10.3.1 Middle East and Africa Fibrin Based Bioadhesive Sales by Country (2017-2028)
10.3.2 Middle East and Africa Fibrin Based Bioadhesive Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Baxter International
11.1.1 Baxter International Corporation Information
11.1.2 Baxter International Overview
11.1.3 Baxter International Fibrin Based Bioadhesive Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Baxter International Fibrin Based Bioadhesive Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Baxter International Recent Developments
11.2 Integra LifeSciences
11.2.1 Integra LifeSciences Corporation Information
11.2.2 Integra LifeSciences Overview
11.2.3 Integra LifeSciences Fibrin Based Bioadhesive Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Integra LifeSciences Fibrin Based Bioadhesive Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Integra LifeSciences Recent Developments
11.3 McKesson Corporation
11.3.1 McKesson Corporation Corporation Information
11.3.2 McKesson Corporation Overview
11.3.3 McKesson Corporation Fibrin Based Bioadhesive Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 McKesson Corporation Fibrin Based Bioadhesive Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 McKesson Corporation Recent Developments
11.4 Vivostat A/S
11.4.1 Vivostat A/S Corporation Information
11.4.2 Vivostat A/S Overview
11.4.3 Vivostat A/S Fibrin Based Bioadhesive Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Vivostat A/S Fibrin Based Bioadhesive Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Vivostat A/S Recent Developments
11.5 Ethicon (Johnson & Johnson)
11.5.1 Ethicon (Johnson & Johnson) Corporation Information
11.5.2 Ethicon (Johnson & Johnson) Overview
11.5.3 Ethicon (Johnson & Johnson) Fibrin Based Bioadhesive Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Ethicon (Johnson & Johnson) Fibrin Based Bioadhesive Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Ethicon (Johnson & Johnson) Recent Developments
11.6 Becton Dickinson
11.6.1 Becton Dickinson Corporation Information
11.6.2 Becton Dickinson Overview
11.6.3 Becton Dickinson Fibrin Based Bioadhesive Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Becton Dickinson Fibrin Based Bioadhesive Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Becton Dickinson Recent Developments
11.7 Adhezion Biomedical
11.7.1 Adhezion Biomedical Corporation Information
11.7.2 Adhezion Biomedical Overview
11.7.3 Adhezion Biomedical Fibrin Based Bioadhesive Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Adhezion Biomedical Fibrin Based Bioadhesive Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Adhezion Biomedical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Fibrin Based Bioadhesive Industry Chain Analysis
12.2 Fibrin Based Bioadhesive Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Fibrin Based Bioadhesive Production Mode & Process
12.4 Fibrin Based Bioadhesive Sales and Marketing
12.4.1 Fibrin Based Bioadhesive Sales Channels
12.4.2 Fibrin Based Bioadhesive Distributors
12.5 Fibrin Based Bioadhesive Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Fibrin Based Bioadhesive Industry Trends
13.2 Fibrin Based Bioadhesive Market Drivers
13.3 Fibrin Based Bioadhesive Market Challenges
13.4 Fibrin Based Bioadhesive Market Restraints
14 Key Findings in The Global Fibrin Based Bioadhesive Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
| 【フィブリン系生体接着剤について】 フィブリン系生体接着剤は、組織再生や創傷治癒の支援に利用される生体適合性のある接着剤の一種であり、主にフィブリンというタンパク質を基にしています。この接着剤は、生体内での使用を目的としており、体内で自然に分解される特性を持っているため、医療分野での応用が広がっています。 フィブリン系生体接着剤の定義としては、生体組織に対して良好な接着性を持ち、かつ生体内での使用に適した材料から構成される接着剤とされています。その基盤となるフィブリンは、血液凝固過程で生成されるタンパク質であり、傷口の修復に重要な役割を果たします。このフィブリンを使用することで、創傷治癒を促進し、手術後の合併症を軽減することが可能になります。 フィブリン系生体接着剤の特徴として、まず第一に生体適合性があります。すなわち、体内に投与してもアレルギー反応や拒絶反応が起こりにくいという特性です。これにより、患者への負担を軽減し、手術後の回復を円滑にします。また、フィブリン系接着剤は生体内で自然に分解されるため、長期間体内に残ることがなく、安全面でも配慮されています。 次に、フィブリン系生体接着剤は、優れた接着性能を持っています。接着剤が組織間にしっかりと接着することで、患部の安定を保ちつつ、組織再生を促す環境を提供します。高い強度と耐久性も特徴であり、フィブリンが形成するネットワークによって、組織が再生される際の基盤となります。さらに、フィブリン系生体接着剤は、出血を抑える効果も確認されており、止血効果を期待できるため、出血を伴う手術などにおいて非常に有用です。 フィブリン系生体接着剤の種類としては、フィブリンスコアやフィブリンダスパー、フィブリンフォームなどがあります。フィブリンスコアは、フィブリンを含むシート状の材料で、特に広範囲な接着が求められる場合に利用されます。フィブリンダスパーは、フィブリンを使った液体状の接着剤で、細かい部位の接着や複雑な構造への利用が可能です。そして、フィブリンフォームは、泡状のフィブリン材料であり、創傷のドレッシングや塞栓材として使用されます。これらの各種類は、その特性に応じて、具体的な応用シーンが異なるため、用途に合わせた選択が求められます。 フィブリン系生体接着剤の主な用途としては、外科手術、オルガン移植、創傷治癒、歯科、整形外科など多岐にわたります。具体的には、外科手術においては、血管や神経の接合、皮膚の閉創などに利用され、スムーズな回復を促進する役割を果たします。オルガン移植の場合、移植片と受容体の組織を確実に接着させることで、新しい器官が体内でしっかりと定着することを助けます。また、創傷治癒においては、傷口を速やかに閉じることができ、感染のリスクを低減させます。 歯科分野では、フィブリン系生体接着剤は歯の治療や補綴、修復時に使用されることがあります。特に、歯周病治療においては、組織の再生を促すために有効です。整形外科では、骨折や関節の修復時にフィブリンを基にした接着剤が使用され、その強度と生体適合性のおかげで、手術後の早期回復が期待できます。 フィブリン系生体接着剤に関連する技術としては、エンドトキシン除去技術や生体適合性向上技術などが挙げられます。エンドトキシン除去技術は、フィブリン素材から毒性のある物質を取り除くための方法であり、これによって患者へのリスクを軽減します。生体適合性向上技術は、フィブリンの加工や添加物の利用を通じて、接着剤の性能を向上させるものです。これにより、より安全で効果的なフィブリン系生体接着剤の開発が進められています。 最後に、今後の展望として、フィブリン系生体接着剤は遺伝子治療や再生医療などの先端医療にも応用が期待される分野です。生体材料との組み合わせや、薬物送達システムとの統合など、多様な可能性があります。これにより、さらなる機能性と効果を持つ接着剤が開発され、医療の現場で活用されることでしょう。 以上のように、フィブリン系生体接着剤はその生体適合性、優れた接着性能、広範囲な用途などが特徴的であり、医療分野において重要な役割を果たしています。今後も技術革新が進む中で、さらなる応用が期待される注目の材料です。 |